LABP - Landos Biopharma GAAP EPS of -$0.13 beats by $0.04 March, 23 2023 09:15 AM Landos Biopharma Inc. 2023-03-23 09:15:04 ET Landos Biopharma press release ( NASDAQ: LABP ): Q4 GAAP EPS of -$0.13 beats by $0.04 . cash and cash equivalents as of December 31, 2022 of $36.64 million. For further details see: Landos Biopharma GAAP EPS of -$0.13 beats by $0.04